- Home
- SATL vs AVTX Comparison
SATL vs AVTX Comparison
Compare SATL & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$1.87
HOLD
Current Price
$18.08
Company Overview
Basic Information| Metric | SATL | AVTX |
|---|---|---|
| Founded | 2010 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 211.3M | 248.3M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | SATL | AVTX |
|---|---|---|
| Price | $1.87 | $18.08 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $32.29 |
| AVG Volume (30 Days) | ★ 3.8M | 313.5K |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $14,684,000.00 | $192,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.26 | $3.39 |
| 52 Week High | $5.12 | $20.72 |
Technical Indicators
Market Signals| Indicator | SATL | AVTX |
|---|---|---|
| Relative Strength Index (RSI) | 48.52 | 49.96 |
| Support Level | $1.95 | $18.58 |
| Resistance Level | $2.25 | $19.97 |
| Average True Range (ATR) | 0.18 | 1.29 |
| MACD | -0.00 | -0.19 |
| Stochastic Oscillator | 13.33 | 27.60 |
Price Performance
Historical Comparison SATL
AVTX
About SATL Satellogic Inc.
Satellogic Inc is a provider of satellite imagery to governments and commercial customers globally. It geographically operates in North America, Europe, Asia and South America. It derives maximum revenue from Asia Pacific.
About AVTX Avalo Therapeutics Inc.
Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).